Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midostaurin for indolent or smoldering systemic mastocytosis
NL-OMON39686Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of midostaurin, sponsored by University Medical Center Groningen. Started Sep 2013; status: active, not recruiting.
02
Drugs
midostaurin
Beyond the preview
Go deeper on NL-OMON39686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39686.